# A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma

> **NCT01802138** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 6 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** Activated T lymphocyte

## Key facts

- **NCT ID:** NCT01802138
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-06
- **Final completion:** 2018-10-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01802138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01802138, "A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01802138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*